🚨 Supreme Court raises a serious question on medicine pricing. A cancer medicine was cited in court with a PTR of ₹2,700 but an MRP of ₹27,000 — a 10× gap. The Court questioned how patients can be subjected to such a huge disparity and why the authorities responsible for regulating medicine prices had remained silent. When treatment can force families to sell assets, should an essential medicine really have such a massive gap between its retailer price and printed MRP? The Supreme Court has sought answers. The matter is listed again on September 29. What should be the maximum permissible gap between PTR and MRP for essential medicines?
Shubham Kumar Jha 🕉️Share
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.